In the News

After postponing its U.S. plans at the top of this year, Boston Scientific has now secured an earlier-than-previously-expected European approval for its latest transcatheter aortic valve replacement implant.

The first economic modelling of Boston Scientific Corp.’s pulsed field ablation system in U.K.’s National Health Service showed that it is more cost-effective as a treatment for paroxysmal atrial fibrillation compared to standard cryoablation.

The arrival of pulsed-field ablation (PFA) has been heralded by many experts in the field of arrhythmia management as the most significant advance in the treatment of atrial fibrillation (AF) to have emerged in recent years.

A patient who underwent an Endoscopic Sleeve Gastroplasty (ESG) at St Mary’s Hospital in London, a minimally invasive procedure to reduce stomach size, said he feels "much more alive" and "fantastic" after the surgery, which helps reduce food intake by shrinking the stomach by up to 80%.

Boston Scientific is advancing cardiac care access in remote locations through digital solutions. This technology facilitates physicians to connect with Boston Scientific technical experts in real-time, regardless of geographical limitations